Rajendra Badwe

16PUBLICATIONS
95CO-AUTHORS
Statistical theoryApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersWomen's studies (incl. girls' studies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 31, 2026
Reply to: Statistical and Methodological Considerations in the Evaluation of Ultra-Low-Dose Nivolumab.

|Jan 28, 2026
Efficacy and Safety of Ultra-Low-Dose Immunotherapy in Relapsed Refractory Solid Tumors: Phase III Superiority Randomized Trial (DELII).

Vanita Noronha, Vijay Patil, Nandini Menon

|Oct 20, 2025
Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.

Sudeep Gupta, Nita Nair, Rohini W Hawaldar

|Apr 23, 2025
Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Minit Shah, Sushmita Rath, Seema Gulia

|Mar 20, 2025
Prevalence and associated factors of mammography uptake among the women aged 45 years and above: policy implications from the longitudinal ageing study in India wave I survey.

Priyanka Sharma, Dipak Das, Divya Khanna

|Jan 31, 2025
Management of Idiopathic Granulomatous Mastitis: Effectiveness of a Steroid-Free Regimen Using Tinospora cordifolia-A Single-Institution Experience.

Ankita Das Sheth, Shalaka Joshi, Arul Kumar

Pageof 3

Frequent Collaborators

9 joint publications

Nita S Nair

9 joint publications

Shalaka Joshi

8 joint publications

Sudeep Gupta

7 joint publications

Rohini W Hawaldar